Estar Medical, the maker of Eclipse PRP® and Tropocells®, has signed an exclusive long-term marketing and distribution agreement with Aesthetic Management Partners, LLC (AMP), to sell its PRP products in the U.S. market.
Read Press ReleaseThe acquisition of TheraCell, Inc. will expand access for two best-in-class product portfolios and build upon Isto's continued commitment to putting patients and their surgical champions first.
Read Press ReleaseCompanies have also entered into a joint development agreement which will merge technologies with the aim to bring innovative products for consumer electronics market.
Read Press ReleaseAlliance for Stem Cell Therapy Now Ms. Janet Marchibroda will moderate the Safety industry panel hosted by AASCP in Miami on November 2, 2019 and will be broadcast live.
Read Press ReleaseAgreement further supports Parametrics' and DePuy Synthes' shared commitment to a comprehensive sports medicine procedural focus as physicians care for a broader patient population
Read Press ReleaseThis three-part webinar series reviews the key considerations for design and conduct of a development plan for a monoclonal antibody (mAb) product.
Read Press ReleaseCandidacy analysis for pipeline agents reveals that JAK inhibitors, such as Pfizer's PF-0496582, AbbVie's upadacitinib and Incyte's topical ruxolitinib have the most potential upside if approved
Read Press ReleaseThe majority of patients started on Xeljanz have failed multiple biologics, but some gastroenterologists see the brand securing a role in the pre-biologic space in the near future, according to the latest quarterly report from Spherix Global Insights
Read Press ReleaseAt the heart of key challenges facing biologics laboratories today lies the volume and complexity of data created throughout the scientific process
Read Press ReleaseFactors, such as growing incidence of cancer cases and lifestyle diseases globally, the cost-effectiveness of biosimilars over biologics, and strategic collaboration to develop new biosimilar drugs will increase the market growth during the forecast period.
Read Press ReleasePresentation to highlight the approaches used in developing consistent cell-based potency assays meeting regulatory expectations (USP <1032> and <1033>) and are suitable for CGMP stability testing
Read Press ReleaseImmunotherapeutics field is rapidly advancing at an unprecedented rate, as estimated by IQ4I Research that the immunotherapeutics global market is expected to reach $138.9 billion by 2021.
Read Press ReleaseHigh purity tubing and single use systems manufacturer AdvantaPure has appointed Tony Butler to a new position focusing on single use systems for pharmaceutical and biologics manufacturing. The role arose because of the company's continued growth.
Read Press ReleaseThe organisation team of the international Drug-Drug Interaction (DDI) Workshop in Marbach Castle on Lake Constance is happy to report the great acceptance and success of the events series in its fourth year. More than 70 drug development experts and
Read Press ReleaseRadolfzell, Germany, November 28th 2012: The organisation team of the International DDI Workshop presents the preliminary programme of the DDI 2013 - 4th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Precli
Read Press Release